Cellebrite DI (CLBT) Shares Outstanding (Weighted Average) (2019 - 2025)

Cellebrite DI's Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $241.6 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 15.35% year-over-year to $241.6 million; the TTM figure through Dec 2025 stood at $241.6 million (up 15.35% YoY), while the FY2025 annual figure was $241.6 million, up 17798.25% from the prior year.
• Shares Outstanding (Weighted Average) was $241.6 million for Q4 2025 at Cellebrite DI, up from $240000.0 in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $241.6 million in Q4 2025 to a low of $1000.0 in Q1 2021.
• Historically, Shares Outstanding (Weighted Average) has averaged $58.2 million across 5 years, with a median of $420000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) surged 31827.93% in 2023, then plunged 99.22% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $144.0 million in 2021, then climbed by 26.87% to $182.7 million in 2022, then advanced by 4.08% to $190.2 million in 2023, then climbed by 10.16% to $209.5 million in 2024, then rose by 15.35% to $241.6 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $241.6 million (Q4 2025), $240000.0 (Q3 2025), and $150000.0 (Q2 2025), per Business Quant data.